Finance

Lists
524572:BOM
Pharmaids Pharmaceuticals Ltd
30,59 INR
+0,46%
(+0,14) 1D
16 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524572...
Open
30,35 INR
High
32,50 INR
Low
29,80 INR
Mkt. cap
1,06 მლრდ.
Avg. vol.
3,45 ათ.
Volume
3,76 ათ.
52-wk high
53,90 INR
52-wk low
25,60 INR
EPS
-1,29 INR
Shares outstanding
3,41 მლნ.
No. of employees
127
Open
30,35 INR
High
32,50 INR
Low
29,80 INR
Mkt. cap
1,06 მლრდ.
Avg. vol.
3,45 ათ.
Volume
3,76 ათ.
52-wk high
53,90 INR
52-wk low
25,60 INR
EPS
-1,29 INR
Shares outstanding
3,41 მლნ.
No. of employees
127
News stories
From web sources and news partners
www.foreignpolicyjournal.com
www.foreignpolicyjournal.com
·
6 წუთის წინ
Super Micro Computer (NASDAQ: SMCI) Signals Were Visible Before Its Stock 45% Rally
AskTraders.com
AskTraders.com
·
1 საათის წინ
S&P 500 Can Absorb Fed Hikes, Says UBS CIO After Hot US Inflation
Yahoo Finance
Yahoo Finance
·
10 საათის წინ
Michael Burry Warns of a Stock Market ‘Supervolcano’
About Pharmaids Pharmaceuticals Ltd
CEO-
Employees127
Founded1989
Headquarters-
SectorPharmaceutical industry
Last report
12 აგვ. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
41,21 მლნ. / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
86,05 მლნ.
54,30 მლნ.
71,84 მლნ.
41,21 მლნ.
Cost of goods sold
75,50 მლნ.
23,48 მლნ.
45,15 მლნ.
16,17 მლნ.
Cost of revenue
75,50 მლნ.
23,48 მლნ.
45,15 მლნ.
16,17 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31,81 მლნ.
32,83 მლნ.
76,78 მლნ.
24,66 მლნ.
Operating expense
68,44 მლნ.
60,62 მლნ.
34,80 მლნ.
37,34 მლნ.
Total operating expenses
143,95 მლნ.
84,10 მლნ.
79,94 მლნ.
53,52 მლნ.
Operating income
-57,90 მლნ.
-29,80 მლნ.
-8,11 მლნ.
-12,30 მლნ.
Other non operating income
2,22 მლნ.
760,00 ათ.
-2,73 მლნ.
483,00 ათ.
EBT including unusual items
-36,57 მლნ.
-40,22 მლნ.
-14,56 მლნ.
24,14 მლნ.
EBT excluding unusual items
-66,45 მლნ.
-36,22 მლნ.
-12,62 მლნ.
-17,86 მლნ.
Income tax expense
-11,29 მლნ.
-13,76 მლნ.
-3,71 მლნ.
5,43 მლნ.
Effective tax rate
30,87%
34,20%
25,48%
22,49%
Other operating expenses
31,96 მლნ.
23,04 მლნ.
-46,75 მლნ.
7,83 მლნ.
Net income
-24,80 მლნ.
-24,79 მლნ.
-18,09 მლნ.
22,05 მლნ.
Net profit margin
-28,83%
-45,65%
-25,18%
53,51%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1,54 მლნ.
-
Interest expense
-10,77 მლნ.
-7,18 მლნ.
-4,36 მლნ.
-6,04 მლნ.
Net interest expenses
-10,77 მლნ.
-7,18 მლნ.
-2,82 მლნ.
-6,04 მლნ.
Depreciation and amortization charges
4,68 მლნ.
4,76 მლნ.
4,77 მლნ.
4,86 მლნ.
EBITDA
-52,53 მლნ.
-25,07 მლნ.
-4,50 მლნ.
-7,23 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები